0001209191-12-028568.txt : 20120516
0001209191-12-028568.hdr.sgml : 20120516
20120516161058
ACCESSION NUMBER: 0001209191-12-028568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120514
FILED AS OF DATE: 20120516
DATE AS OF CHANGE: 20120516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazur Marc
CENTRAL INDEX KEY: 0001361226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31564
FILM NUMBER: 12848924
MAIL ADDRESS:
STREET 1: 31 WEST 52ND ST. 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fibrocell Science, Inc.
CENTRAL INDEX KEY: 0000357097
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870458888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 405 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 484-713-6000
MAIL ADDRESS:
STREET 1: 405 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: ISOLAGEN INC
DATE OF NAME CHANGE: 20020320
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE
DATE OF NAME CHANGE: 19960330
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO
DATE OF NAME CHANGE: 19921008
4
1
c28777_4x0.xml
MAIN DOCUMENT DESCRIPTION
X0305
4
2012-05-14
0000357097
Fibrocell Science, Inc.
FCSC
0001361226
Mazur Marc
C/O 405 EAGLEVIEW BOULEVARD
EXTON
PA
19341
1
0
0
0
Series E Preferred Stock
.25
2012-05-14
4
A
0
100000
A
Common Stock
100000
500000
D
Warrant to Purchase Common Stock
.30
2012-05-14
4
A
0
100000
A
Common Stock
100000
600000
D
The Series E Preferred Stock is immediately exercisable and does not have an expiration date.
Each share of Series E Preferred Stock and each Warrant were purchased together as a Unit, for a combined purchase price of $1,000 per Unit. Mr. Mazur purchased 25 Units, for a total purchase price of $25,000.
The Warrants may be exercised beginning on the date on which the Company receives approval from its shareholders to file, and subsequently files, an amendment to its Certificate of Incorporation increasing the number of its authorized shares of Common Stock to an amount greater than 250,000,000 shares.
The Warrants expire 5 years after the initial exercise date described in Footnote 3.
Marc Mazur
2012-05-16